Tiziana Life Sciences LTD reports a Return on Equity (ROE) of -60,138.46%.

What is TLSA's dividend yield?

Tiziana Life Sciences LTD offers a dividend yield of 0.00%.

What is TLSA's Quality Score?

Our AI rates TLSA's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy TLSA?

Our AI Timing Score for TLSA is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does TLSA belong to?

Tiziana Life Sciences LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Tiziana Life Sciences LTD (TLSA) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

TLSA AI Analysis Summary

Our AI summary for TLSA: Tiziana Life Sciences LTD (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -60,138.46%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

TLSA

Tiziana Life Sciences LTD

US:NASDAQ STOCK Healthcare >> Biotechnology News 88

USD 0.97

-0.00 (-0.18%) Day Change

Watchlist Portfolio Compare Chart

4.27

D/E

-60,138.5%

ROE

-272.1%

ROA

0.00%

Div Yield

TIZIANA LIFE SCIENCES LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.97 Price -0.00 (-0.18%) Day Change	NEWS SCORE: 88

TLSA, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	88
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.97
PBV / Sector	2,372.16 / 44,022.72
Earning Per Share	-0.25

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	0.44 M GREAT
Average 1W Daily Value	0.79 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.24
NPM Average (%) / Sector	N/A / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-272.05 / 185,260.96
ROA Average (%) / Sector	-158.50 / 36,684.70
ROA Change Average (%) / Sector	59.06 / 422,221.66 GREAT
ROE (%) / Sector	-60,138.46 / 243,762.23
ROE Average (%) / Sector	-19,276.94 / 48,758.47
ROE Change Average (%) / Sector	3,005.50 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:57
Symbol	TLSA
Name	TIZIANA LIFE SCIENCES LTD
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	127.26 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	123.35 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 14/15 Conduit Street, London, United Kingdom, W1S 2XJ

Phone: 44 20 7495 2379

Website: https://www.tizianalifesciences.com

Sector: Healthcare >> Biotechnology

Description: Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.